Nippon Chemiphar Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nippon Chemiphar Co., Ltd. with three other
companies in this sector in Japan:
Fuso Pharmaceutical Industries Ltd
sales of 46.78 billion Japanese Yen [US$414.02 million]
of which 100%
was Pharmaceutical Business),
(29.59 billion Japanese Yen [US$261.86 million]
of which 82%
was Pharmaceutical Products), and
Eiken Chemical Co., Ltd.
(33.27 billion Japanese Yen [US$294.47 million]
of which 54%
was Immunoserology Test Agent).
During the year ended March of 2017, sales at
Nippon Chemiphar Co., Ltd. were ¥35.69 billion (US$315.85 million).
a very small
increase of 0.2%
versus 2016, when the company's sales were ¥35.60 billion.
This was the third consecutive year of growth at Nippon Chemiphar Co., Ltd..
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
4.1% in 2017, from
¥1.09 billion to ¥1.14 billion.